Brief: Genprex Announces $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
July 19 (Reuters) - Genprex Inc GNPX.O :
* GENPREX ANNOUNCES $7.5 MILLION REGISTERED DIRECT OFFERING
PRICED
AT-THE-MARKET UNDER NASDAQ RULES
* SALE AT A COMBINED OFFERING PRICE OF $1.01 PER SHARE
Source text for Eikon: ID:nPn1stWjba
Further company coverage: GNPX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy